DNA Sequencing Market Report 2026

DNA Sequencing Market Overview

• DNA Sequencing market size has reached to $15.8 billion in 2025 • Expected to grow to $34.15 billion in 2030 at a compound annual growth rate (CAGR) of 16.8% • Growth Driver: Surge In Cancer Cases Accelerates The DNA Sequencing Market Growth • Market Trend: Leading Companies Spearhead Innovations With Production-Scale Sequencing In The DNA Sequencing Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under DNA Sequencing Market?

DNA sequencing refers to determining a DNA molecule's precise order or sequence of nucleotides (adenine, cytosine, guanine, and thymine). It is a fundamental molecular biology and genetics technique that allows scientists to unravel the genetic code within an organism's DNA. The main products of DNA sequencing are instruments, consumables, and services. Instruments are mechanical tools or implements, particularly those used for delicate or precise operations, and DNA sequencing instruments are designed to automate and carry out the steps involved in sequencing DNA samples. It includes various technologies such as third-generation DNA sequencing, next-generation sequencing, and sanger sequencing applied in diagnostics, biomarkers and cancer, reproductive health, personalized medicine, forensics, and others. It is used by hospitals and healthcare organizations, academics and research institutions, pharmaceutical and biotechnology companies, and others.

What Is The DNA Sequencing Market Growth Forecast?

The dna sequencing market size is expected to see rapid growth in the next few years. It will grow to $34.15 billion in 2030 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to precision medicine expansion, population genomics initiatives, ai-enabled data analysis, oncology diagnostics growth, clinical sequencing reimbursement support. Major trends in the forecast period include rising adoption of next-generation sequencing technologies, expansion of sequencing in clinical diagnostics, growing use in cancer and rare disease research, integration of sequencing with bioinformatics platforms, increasing demand for high-throughput sequencing services.

Global DNA Sequencing Market Segmentation

1) By Product: Instruments, Consumables, Services 2) By Technology: Third Generation DNA Sequencing, Next-Generation Sequencing, Sanger Sequencing 3) By Application: Diagnostics, Biomarkers And Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications 4) By End User: Hospitals And Healthcare Organizations, Academics And Research Institutions, Pharmaceutical And Biotechnology Companies, Other End Users Subsegments: 1) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Single-Molecule Sequencing Instruments 2) By Consumables: Reagents, Kits, Chips And Flow Cells 3) By Services: Sequencing Services, Data Analysis Services, Bioinformatics Services

What Is The Driver Of The DNA Sequencing Market?

The increasing prevalence of cancer is expected to propel the growth of the DNA sequencing market going forward. Cancer refers to the uncontrolled growth and spread of abnormal cells that can invade or destroy healthy tissues across various organs. The prevalence of cancer is rising due to aging populations, lifestyle risk factors, environmental exposures, and improved detection methods. DNA sequencing market supports this trend by enabling the identification of genetic mutations, deeper understanding of tumor biology, and personalized treatment decisions that improve patient outcomes. For instance, in January 2024, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of cancer cases increased to 2,001,140 in 2024, up from 1,958,310 in 2023, reflecting a 2.19% rise. Therefore, the increasing prevalence of cancer is driving the growth of the DNA sequencing industry.

Key Players In The Global DNA Sequencing Market

Major companies operating in the dna sequencing market are F. Hoffmann-La Roche Ltd, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics, Myriad Genetics Inc., Natera Inc., 10x Genomics Inc., GenScript Biotech Corporation, Novogene Corporation, Twist Bioscience, Genewiz LLC, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Macrogen Inc., LI-COR Inc., MGI Tech Co. Ltd., Zymo Research Corporation, Igenomix, Codex DNA, GenapSys Inc., SeqOnce Biosciences Inc.

Global DNA Sequencing Market Trends and Insights

Major companies operating in the global DNA sequencing market are focusing on developing innovative platforms such as compact, affordable benchtop sequencers and real-time analysis solutions to expand accessibility, accelerate turnaround times, and enhance the scalability of genomic testing. These advanced sequencing platforms refer to next-generation instruments and software systems designed to reduce cost per genome, increase throughput, support decentralized testing, and enable faster results for clinical and research applications. For instance, in October 2024, Illumina Inc., a US-based biotechnology company, announced the launch of its new MiSeq i100 gene sequencers smaller, lower-cost benchtop devices capable of producing results in approximately four hours and priced at USD 49,000 for the base model designed to make high-throughput sequencing accessible to more research and testing labs and thereby drive innovation across the DNA sequencing. These compact systems offer enhanced efficiency without compromising data quality. Their affordability allows smaller institutions to adopt advanced sequencing technologies that were previously out of reach.

What Are Latest Mergers And Acquisitions In The DNA Sequencing Market?

In March 2024, Clinical Microbiomics, a Denmark-based contract research organization, acquired DNASense ApS for an undisclosed amount. Through this acquisition, Clinical Microbiomics aims to enhance its long-read DNA and RNA sequencing capabilities to enable deeper exploration of microbiome complexities and accelerate advancements in microbiome and metabolome research. DNASense ApS is a Denmark-based microbiome CRO specializing in long-read DNA and RNA sequencing technologies.

Regional Outlook

North America was the largest region in the DNA sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the DNA Sequencing Market?

The DNA sequencing market consists of revenues earned by entities by providing bioinformatics and data analysis software and sequencing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The DNA sequencing market also includes sales of DNA sequencing kits, sequencing reagents, and laboratory equipment used in providing DNA sequencing services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the DNA Sequencing Market Report 2026?

The dna sequencing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the dna sequencing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.